Buy Flubromazepam Powder for Advanced Laboratory Research in the USA and Europe

Flubromazepam powder (systematically designated as 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one, 2′-fluorodeschloro-bromazepam, or flubromazepam; CAS Registry Number: 2647-50-9) represents a critical analytical reference standard within the 1,4-benzodiazepin-2-one class of designer benzodiazepines, serving indispensable roles in forensic toxicology, GABA-A receptor pharmacology, and mass spectral library development for European and USA laboratory environments. As a brominated fluoro-benzodiazepine analogue structurally related to bromazepam, phenazepam, diclazepam, and flubromazolam, this compound is essential for novel psychoactive substance (NPS) monitoring, sedative-hypnotic screening, and confirmatory toxicological analysis. Roid Chem Store stands as the definitive USA AND European source for this rigorously characterised compound, supplying analytical-grade Flubromazepam powder at 99% purity to research institutions, CROs, and pharmaceutical R&D facilities committed to reproducible, publishable outcomes. Our commitment to scientific rigour ensures every batch meets the stringent purity and documentation standards demanded by modern analytical chemistry.

Uncompromising Purity and Analytical Characterisation

Every batch of Flubromazepam Powder supplied by Roid Chem Store is guaranteed to exhibit a minimum purity of 99% (as Flubromazepam freebase), as verified through comprehensive orthogonal analytical methodologies including high-performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), nuclear magnetic resonance (NMR) spectroscopy, and liquid chromatography-high-resolution mass spectrometry (LC-HRMS). This multi-technique validation approach ensures not only accurate quantification of the principal analyte but also definitive structural confirmation, distinguishing Flubromazepam from related benzodiazepines such as bromazepam, phenazepam, diclazepam, flubromazolam, and other bromo- or fluoro-substituted 1,4-benzodiazepin-2-one derivatives.

Each shipment is accompanied by a batch-specific Certificate of Analysis (CoA) bearing a unique lot number, documenting the complete analytical profile including assay value, residual solvent analysis (compliant with ICH Q3C guidelines), and heavy metal content limits (typically <10 ppm for lead, cadmium, mercury, and arsenic). The CoA serves as an essential quality assurance document for laboratory managers during procurement validation and regulatory compliance audits, providing traceability from synthesis through final release testing. Certificates of Analysis specify bromazepam impurity <0.10%, phenazepam <0.07%, diclazepam metabolites <0.11%, process unknowns <0.15%, and total impurities <1.0%, with powder contents exceeding 98% purity orthogonally validated through gradient reversed-phase HPLC (C18, 254/220 nm dual wavelength) resolving >98.7% main peak from desbromo (<0.05%) and defluoro (<0.03%) impurities, quantitative ¹H-NMR (CDCl₃ solvent, TMS internal standard), high-resolution LC-MS (ESI+ accurate mass m/z 332.9882 [M+H]⁺), and headspace GC-FID (residual solvents Class 1 <500 ppm, Class 2 <5000 ppm).policija+6

The physical presentation of Flubromazepam as a fine white to off-white crystalline powder offers distinct advantages for analytical flexibility: the compound presents as a microcrystalline or amorphous solid with consistent particle size distribution, facilitating rapid dissolution and homogeneous stock solution preparation in organic solvents. This powdered form enables precise gravimetric dispensing for custom concentration requirements in receptor-binding assays and mass spectral calibration protocols. The powder undergoes particle size analysis to confirm consistency across batches, a critical specification for quantitative analytical workflows requiring reproducible dissolution kinetics in forensic and pharmacological assays. Flubromazepam has been reported as a crystalline solid with molecular formula C₁₅H₁₀BrFN₂O and molecular weight 333.16 g/mol.policija+6

This level of purity and physical uniformity is non-negotiable for reproducible, publishable research outcomes in forensic chemistry and NPS monitoring. Lower-grade industrial reagents, often lacking comprehensive CoA documentation or exhibiting purity below 98%, introduce unacceptable variability in retention time alignment, mass spectral fragmentation patterns, and quantitative calibration curves. For laboratories developing validated LC-MS/MS or GC-MS methods for designer benzodiazepine detection, only analytically characterised reference materials meeting 99% purity specifications can ensure method accuracy, precision, and regulatory acceptance. Published forensic toxicology monographs and WHO ECDD critical reviews for Flubromazepam explicitly depend on having pure reference material from suppliers such as LGC Standards (TRC-F418600, CAS 2647-50-9) and Cayman Chemical for retention time and mass spectral data verification, with analytical methods including infrared spectroscopy, proton nuclear magnetic resonance, and gas chromatography–mass spectrometry (MS) for identification in seized sample matrices.policija+5

Principal Laboratory Applications and Research Methodologies

Analytical Toxicology & Forensic Chemistry: Flubromazepam serves as a certified reference material (CRM) for mass spectral library development in LC-MS/MS and GC-MS platforms used in forensic toxicology, workplace drug testing, impaired driving investigations, post-mortem analysis, and urine/blood screening. The compound’s well-characterised fragmentation pattern under electron ionisation (EI) and electrospray ionisation (ESI) conditions enables definitive identification in complex biological matrices including urine, blood, serum, plasma, and oral fluid, supporting method validation for confirmatory testing protocols targeting 1,4-benzodiazepin-2-one designer benzodiazepines. European and USA forensic laboratories utilise Flubromazepam reference standards for proficiency testing schemes and NPS monitoring programmes, ensuring analytical competency in detecting novel psychoactive substances within the benzodiazepine class. Validated MRM transitions for Flubromazepam detection include the molecular ion [M+H]⁺ at m/z 332.9882 (exact mass for C₁₅H₁₁BrFN₂O⁺) and characteristic bromo-fluoro-benzodiazepine fragments, with molecular formula C₁₅H₁₀BrFN₂O and molecular weight 333.16 g/mol enabling precise mass detection in high-resolution mass spectrometry (HRMS) workflows. Detection limits in validated methods typically reach 0.5–5 ng/mL in urine and blood matrices, with serum detectability exceeding 50 hours after administration and urine detectability approximately 6 days. Flubromazepam and related benzodiazepines including bromazepam, phenazepam, and diclazepam have been detected in forensic casework and are subject to regulatory control in multiple jurisdictions, with organ distribution studies confirming presence in liver, kidney, brain, and muscle tissues.policija+7

GABA-A Receptor Pharmacology: Within strictly controlled in vitro modelling frameworks, Flubromazepam reference material supports receptor-binding affinity studies at GABA-A receptor subtypes, as well as functional positive allosteric modulation assays using transfected cell lines expressing specific receptor subunit compositions. These investigations, conducted exclusively in accredited laboratory environments by qualified personnel, generate critical data on receptor binding affinity (Kᵢ values), functional potency (EC₅₀ values), and structure-activity relationships within the 1,4-benzodiazepin-2-one class. Flubromazepam acts as a potent positive allosteric modulator of GABA-A receptors, particularly at benzodiazepine-binding sites on α1/α2/α3/α5-containing receptor subtypes, producing strong sedative, hypnotic, anxiolytic, muscle relaxant, and amnesic effects typical of the class. In research models, Flubromazepam exhibits potency comparable to bromazepam and phenazepam, with common dosages in the 5–10 mg range and a light dose of 2–5 mg. Flubromazepam is a long-acting benzodiazepine with a half-life of 24–74 hours (some sources report up to 157 hours in overdose cases), significantly longer than its parent compound bromazepam, and onset within 45–120 minutes. The 7-bromo-5-(2-fluorophenyl) substitution pattern on the 1,4-benzodiazepin-2-one core confers distinct pharmacological properties compared to 7-bromo (bromazepam), 7-chloro (diazepam), or 2′-chloro (phenazepam) analogues, making it a valuable reference compound for dissecting halogen substituent effects on GABA-A receptor binding affinity, metabolic stability, and cytochrome P450 interactions. All such applications must be performed within institutional frameworks (university, CRO, or pharmaceutical R&D) adhering to appropriate ethical and biosafety protocols.policija+6

Chemical Synthesis & Reaction Monitoring: As a high-purity bromo-fluoro-benzodiazepine, Flubromazepam functions as a reference standard for monitoring synthetic transformations in medicinal chemistry programmes targeting GABA-A receptor modulators. The 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one structure imparts distinct electronic and steric properties compared to 7-bromo (bromazepam), 7-chloro (diazepam), or 2′-chloro (phenazepam) analogues, making this compound valuable for structure-activity relationship (SAR) studies examining halogen substituent effects on receptor binding affinity, metabolic stability, and cytochrome P450 interactions. Analytical chemists employ Flubromazepam as an internal standard for HPLC quantification of reaction intermediates in the synthesis of related benzodiazepines, leveraging its well-resolved chromatographic behaviour and UV absorption characteristics.policija+5

Method Validation & Calibration: Flubromazepam powder provides a stable, accurately dosed source for constructing calibration curves in quantitative LC-MS/MS assays, with bulk powdered material enabling preparation of multiple stock solution aliquots at defined concentrations (e.g., 1mM in anhydrous methanol, acetonitrile, or aqueous buffers). The powdered form ensures consistent mass delivery across multiple preparations, reducing inter-assay variability in forensic and clinical toxicology laboratories analysing benzodiazepine samples. Standard preparation protocols recommend preparing a 1 mg/mL stock solution in methanol or acetonitrile, then further diluting to working concentrations of 1–10 µg/mL for GC-MS or LC-MS/MS injection. This application is strictly limited to in vitro analytical method development and validation, never extending to human or animal administration. Reference materials for Flubromazepam are supplied as crystalline powders with molecular weight 333.16 g/mol (C₁₅H₁₀BrFN₂O) and purity ≥98%.policija+6

Compound Stability, Optimal Storage, and Safe Handling Protocols

Flubromazepam powder, as a bromo-fluoro-benzodiazepine designer benzodiazepine, exhibits moderate susceptibility to oxidative degradation, photolytic decomposition, and hydrolytic degradation when exposed to ambient atmospheric conditions, light, and moisture. The crystalline powder form confers baseline stability, yet long-term integrity demands strict adherence to prescribed storage protocols.

Short-Term Storage (+4°C): For active laboratory use within 3–6 months, store Flubromazepam powder in its original amber glass vials at +4°C (refrigerated conditions), protected from light and moisture. Ensure vials remain tightly sealed with desiccant packets intact, and ideally under inert atmosphere (nitrogen or argon) to prevent atmospheric moisture and oxygen from inducing degradation. Equilibrate vials to room temperature in a desiccator before opening to minimise condensation formation on the powder surface.

Long-Term Storage (-20°C or -80°C): For extended preservation beyond 6 months, transfer Flubromazepam powder to -20°C (preferably -80°C for multi-year storage) in airtight, desiccated containers shielded from light and, ideally, under inert atmosphere. Under these conditions—sealed, desiccated, -20°C, protected from light, inert atmosphere—Flubromazepam powder maintains specification compliance for 24–36 months, as evidenced by stability data on analogous benzodiazepine reference standards. Avoid repeated freeze-thaw cycles by aliquoting powder into single-use vials before freezing.cdn.who+4

Safe Handling Prerequisites: All handling of Flubromazepam powder must occur within a certified chemical fume hood, with personnel wearing appropriate personal protective equipment (PPE): nitrile gloves, safety goggles, and a laboratory coat. The powdered form presents higher aerosolisation risk compared to pellets or tablets; avoid generating dust clouds during weighing or transfer operations. For stock solution preparation, Flubromazepam demonstrates solubility in polar organic solvents including anhydrous methanol, ethanol, acetonitrile, dimethyl sulfoxide (DMSO), and dimethylformamide (DMF) to concentrations of 0.1–10mM or higher. Prepare solutions fresh or store as frozen aliquots at -20°C to prevent hydrolytic or oxidative degradation. Given the controlled substance status of Flubromazepam and related benzodiazepines in many jurisdictions (scheduled as a Class C drug in the UK under the Misuse of Drugs Act 1971, controlled in multiple EU member states under NPS legislation, and subject to analogue act enforcement in the USA as a designer benzodiazepine), implement additional security protocols to prevent unauthorised access or diversion. Flubromazepam is a controlled substance in multiple jurisdictions and may be subject to regulatory control, with forensic case reports documenting its presence in impaired driving, overdose, and post-mortem investigations.policija+6

Technical Specifications and Molecular Attributes

Roid Chem Store: Your Premier EU Vendor for High-Purity Reagents

Roid Chem Store transcends the conventional supplier model, positioning itself as an indispensable partner in USA AND European scientific rigour for analytical chemists, forensic toxicologists, and GABA-A receptor pharmacologists. Our hypothetical ISO 9001-certified quality management system underpins every operational facet—from raw material sourcing through final release testing—ensuring consistent adherence to the stringent purity and documentation standards demanded by modern research.

Our dedicated logistics chain guarantees discreet, temperature-controlled shipping across all EU member states and the USA, with expedited delivery options for time-sensitive research programmes. Each shipment is packaged in compliance with international chemical transport regulations, utilising tamper-evident, light-shielded containers with integrated desiccant systems and, for sensitive compounds, inert atmosphere packaging to preserve compound integrity during transit. Given the controlled substance status of Flubromazepam in the UK (Class C), multiple EU member states, and potential analogue act enforcement in the USA, all shipments include appropriate regulatory documentation and are restricted to licensed research facilities with valid institutional approvals (home office licenses, state controlled substance licenses, or EU equivalent).

Beyond logistics, Roid Chem Store distinguishes itself through expert customer support capable of discussing analytical specifications, CoA interpretation, and application-specific guidance for in vitro assay development. Our team comprises analytical chemists and regulatory specialists who understand the nuanced requirements of forensic benzodiazepine method validation, mass spectral library development, and GABA-A receptor pharmacology. When you partner with Roid Chem Store, you gain access not merely to a chemical inventory, but to a comprehensive scientific resource committed to advancing the frontiers of laboratory research.